NDC 0517-2502

Caffeine and Sodium Benzoate

Caffeine And Sodium Benzoate

Caffeine and Sodium Benzoate is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by American Regent, Inc.. The primary component is Caffeine.

• Product ID: 0517-2502_45b3d48f-060b-44bb-82ee-3038d0ed131f
• NDC: 0517-2502
• Product Type: Human Prescription Drug
• Proprietary Name: Caffeine and Sodium Benzoate
• Generic Name: Caffeine And Sodium Benzoate
• Dosage Form: Injection, Solution
• Route of Administration: INTRAMUSCULAR; INTRAVENOUS
• Marketing Start Date: 1993-02-01
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: American Regent, Inc.
• Substance Name: CAFFEINE
• Active Ingredient Strength: 125 mg/mL
• Pharm Classes: Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0517-2502-10

10 VIAL, SINGLE-DOSE in 1 BOX (0517-2502-10) > 2 mL in 1 VIAL, SINGLE-DOSE (0517-2502-01)

• Marketing Start Date: 1993-02-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0517-2502-10 [00517250210]

Caffeine and Sodium Benzoate INJECTION, SOLUTION

• Marketing Category: UNAPPROVED DRUG OTHER
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 1993-02-01

NDC 0517-2502-01 [00517250201]

Caffeine and Sodium Benzoate INJECTION, SOLUTION

• Marketing Category: UNAPPROVED DRUG OTHER
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2018-07-27

Drug Details

Active Ingredients

Ingredient	Strength
CAFFEINE	125 mg/mL

OpenFDA Data

• SPL SET ID: b2c6b352-f837-4903-8e4c-fb0a2b20bb60
• Manufacturer:
  • American Regent, Inc.
• UNII:
  • 3G6A5W338E
• UPC Code:
  • 0305172502100

Pharmacological Class

• Central Nervous System Stimulant [EPC]
• Methylxanthine [EPC]
• Xanthines [CS]
• Central Nervous System Stimulation [PE]